Globus Medical Company Insiders

GMED Stock  USD 82.94  0.05  0.06%   
Globus Medical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Globus Medical stock suggests that all insiders are panicking at this time. Globus Medical employs about 5 K people. The company is managed by 19 executives with a total tenure of roughly 94 years, averaging almost 4.0 years of service per executive, having 263.16 employees per reported executive.
David Paul  Chairman
Co-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance Committee
Brett Murphy  President
Group President of Commercial Operations

Globus Medical's Insider Buying Vs Selling

0

 
Selling
 
Buying

Latest Trades

2024-12-02Kelly HullerDisposed 2500 @ 87View
2024-11-06Kelly HullerDisposed 5000 @ 81.01View
2024-10-16David D DavidarDisposed 30000 @ 75.04View
2024-09-13Ann D RhoadsDisposed 15000 @ 70.36View
2024-07-11Leslie V NorwalkDisposed 1000 @ 70View
2024-05-10Dan LemaitreDisposed 63300 @ 64.61View
2024-05-08David D DavidarDisposed 20000 @ 65View
2024-03-15Leslie V NorwalkDisposed 10590 @ 51.99View
Monitoring Globus Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Globus Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Globus Stock refer to our How to Trade Globus Stock guide.

Globus Medical's Workforce Through the Years

Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Globus Medical's future performance. Based on our forecasts, it is anticipated that Globus will maintain a workforce of about 5000 employees by January 2025.
 
Yuan Drop
 
Covid

Globus Medical Management Team Effectiveness

The company has return on total asset (ROA) of 0.0473 % which means that it generated a profit of $0.0473 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0222 %, meaning that it created $0.0222 on every $100 dollars invested by stockholders. Globus Medical's management efficiency ratios could be used to measure how well Globus Medical manages its routine affairs as well as how well it operates its assets and liabilities. As of December 11, 2024, Return On Tangible Assets is expected to decline to 0.04. In addition to that, Return On Capital Employed is expected to decline to 0.03. At present, Globus Medical's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 82.5 M, whereas Return On Tangible Assets are forecasted to decline to 0.04.
As of December 11, 2024, Common Stock Shares Outstanding is expected to decline to about 104.1 M. In addition to that, Net Income Applicable To Common Shares is expected to decline to about 120.8 M

Globus Medical Workforce Comparison

Globus Medical is rated # 3 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 49,274. Globus Medical retains roughly 5,000 in number of employees claiming about 10% of equities under Health Care industry.

Globus Medical Profit Margins

The company has Profit Margin (PM) of 0.04 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.18 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.18.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.850.6505
Significantly Up
Slightly volatile
Net Profit Margin0.07440.0783
Notably Down
Slightly volatile
Operating Profit Margin0.08060.0849
Notably Down
Slightly volatile
Pretax Profit Margin0.10.1054
Notably Down
Slightly volatile
Return On Assets0.0230.0242
Notably Down
Slightly volatile
Return On Equity0.02920.0307
Notably Down
Slightly volatile

Globus Medical Insider Trading History

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Globus Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Globus Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Globus Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Buy/Sell Ratio# Purchases Trades# Sales TradesTotal Shares PurchasedTotal Shares Sold
2024-12-01
0.5455
12
22
 305,417 
 494,792 
2024-09-01
0.5
3
6
 60,000 
 101,000 
2024-06-01
0.6
3
5
 52,500 
 135,800 
2024-03-01
2.8
14
5
 457,500 
 33,590 
2023-12-01
4.0
4
1
 191,100 
 342,200 
2023-06-01
0.8
4
5
 43,450 
 86,900 
2023-03-01
2.5
15
6
 382,467 
 76,634 
2022-12-01
0.5
1
2
 7,500 
 15,000 
2022-06-01
1.0
2
2
 62,500 
 34,000 
2022-03-01
1.5
15
10
 448,334 
 61,694 
2021-09-01
0.4375
7
16
 104,166 
 210,332 
2021-06-01
0.6667
10
15
 323,022 
 646,044 
2021-03-01
4.3333
13
3
 515,768 
 46,152 
2020-12-01
0.6154
8
13
 70,220 
 331,295 
2020-09-01
0.6471
11
17
 696,305 
 1,060,000 
2020-06-01
0.8
4
5
 109,776 
 218,152 
2019-12-01
0.2857
2
7
 28,076 
 63,536 
2019-09-01
0.5
2
4
 90,000 
 103,000 
2019-06-01
1.0
1
1
 25,000 
 0.00 
2019-03-01
0.7097
22
31
 816,582 
 622,316 
2018-09-01
0.5
4
8
 1,151,812 
 2,011,818 
2018-06-01
0.65
26
40
 793,383 
 1,545,124 
2018-03-01
2.4286
17
7
 741,500 
 172,000 
2017-12-01
0.5
5
10
 73,459 
 175,996 
2017-09-01
1.0
1
1
 300,000 
 15,000 
2017-06-01
0.5
1
2
 16,153 
 32,306 
2017-03-01
6.0
12
2
 627,500 
 115,000 
2016-09-01
0.5
2
4
 107,692 
 215,384 
2016-03-01
2.5
15
6
 585,600 
 60,645 
2015-09-01
1.5
3
2
 215,000 
 20,000 
2015-06-01
0.25
1
4
 3,076 
 206,152 
2015-03-01
1.25
10
8
 532,500 
 2,115,663 
2014-06-01
0.8
4
5
 6,068,500 
 6,098,500 
2014-03-01
1.0625
17
16
 1,323,829 
 2,589,471 
2013-09-01
0.1538
2
13
 102,478 
 21,814,035 
2013-06-01
0.5556
5
9
 2,884,530 
 3,114,530 
2013-03-01
3.3333
10
3
 196,000 
 71,103 
2012-12-01
1.0
1
1
 435,350 
 870,700 
2012-09-01
0.766
36
47
 42,672,634 
 91,741,044 

Globus Medical Notable Stakeholders

A Globus Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Globus Medical often face trade-offs trying to please all of them. Globus Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Globus Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David PaulCo-Founder, Chairman, CEO, Chairman of Compensation Committee and Chairman of Nominating and Corporate Governance CommitteeProfile
Brett MurphyGroup President of Commercial OperationsProfile
Keith PfeilChief Financial Officer, Senior Vice PresidentProfile
David DemskiGroup President of Emerging Technologies, Director and Member of Nominating and Corporate Governance CommitteeProfile
Daniel ScavillaExecutive Vice President, Chief Commercial Officer and President - TraumaProfile
Steve ZarrilliIndependent DirectorProfile
Ann RhoadsIndependent DirectorProfile
James TobinIndependent DirectorProfile
Daniel LemaitreIndependent DirectorProfile
David DavidarCo-Founder, Sr. VP of Operations and DirectorProfile
Kelly EsqGeneral VPProfile
Mike ReederEx OfficerProfile
Robert DouglasIndependent DirectorProfile
Steven PayneVP ControllerProfile
Kelly HullerSenior Vice President General Counsel, Corporate SecretaryProfile
Stephen ZarrilliIndependent DirectorProfile
Brian KearnsSenior RelationsProfile
Richard HolifieldEx OfficerProfile
John DowlingEx OfficerProfile

About Globus Medical Management Performance

The success or failure of an entity such as Globus Medical often depends on how effective the management is. Globus Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Globus management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Globus management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.05  0.04 
Return On Capital Employed 0.03  0.03 
Return On Assets 0.02  0.02 
Return On Equity 0.03  0.03 
Please note, the presentation of Globus Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Globus Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Globus Medical's management manipulating its earnings.

Globus Medical Workforce Analysis

Traditionally, organizations such as Globus Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Globus Medical within its industry.

Globus Medical Manpower Efficiency

Return on Globus Medical Manpower

Revenue Per Employee313.7K
Revenue Per Executive82.6M
Net Income Per Employee24.6K
Net Income Per Executive6.5M
Working Capital Per Employee304.6K
Working Capital Per Executive80.2M

Complementary Tools for Globus Stock analysis

When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Money Managers
Screen money managers from public funds and ETFs managed around the world